Medtronic in.pact drug-eluting balloon studies show significant benefit of novel medical device in treating narrowed arteries Full Text

Adding to the growing body of evidence on a novel interventional cardiovascular device, physicians presented today at EuroPCR 2012 the results of two multicenter, randomized controlled trials, the BELLO and PACIFIER studies, each one showing statistically significant advantages of using an IN.PACT drug–eluting balloon from Medtronic, Inc. (NYSE: MDT) over a corresponding conventional treatment for coronary and peripheral artery disease, respectively.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Pharma News

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Pharma News Articles

1 Is there U-turn from insulin back to pills in diabetes? Current Vascular Pharmacology, July 16, 2014    Clinical Article

2 Sandoz wins biosimilar filing race Full Text Applied Clinical Trials, July 28, 2014    Free full text

3 Generic drug prescribers/dispensers express concern with FDA proposal Full Text American Hospital Association News, July 8, 2014    Free full text

4 Stroke incidence and mortality trends in US communities, 1987 to 2011 JAMA, July 17, 2014    Evidence Based Medicine    Clinical Article

5 Better use of EHRs makes clinical trials less expensive Healthcare Informatics, July 29, 2014

6 Cocaine's fall and marijuana's rise: Questions and insights based on new estimates of consumption and expenditures in US drug markets Addiction, July 18, 2014    Clinical Article

7 Pill-mill crackdown cut Florida’s overdose deaths Full Text Drug Topics, July 9, 2014    Free full text

8 Combination therapy with sitagliptin and lansoprazole in patients with recent-onset type 1 diabetes (REPAIR-T1D): 12-month results of a multicenter, randomized, placebo-controlled, phase 2 trial The Lancet Diabetes & Endocrinology, July 21, 2014    Clinical Article

9 FDA abroad Pharmaceutical Executive Magazine, July 22, 2014

10 Teva files citizen petition with the U.S. food and drug administration (FDA) regarding the complexity of COPAXONE (glatiramer acetate) following the agency's guidance Full Text Teva Pharmaceutical Industries, July 10, 2014    Free full text

11 Daiichi Sankyo submits Savaysa (edoxaban) tablets new drug application to the U.S. FDA for once-daily use for stroke risk reduction in atrial fibrillation and for the treatment and prevention of recurrence of venous thromboembolism Full Text Daiichi Sankyo, July 9, 2014    Free full text

12 The effects of Milk Thistle (Silybum marianum) on human cytochrome P450 activity Drug Metabolism and Disposition, July 16, 2014    Clinical Article

13 ENTYVIO (vedolizumab) now available in the United States for the treatment of adults with UC or CD Takeda Pharmaceuticals U.S.A., June 17, 2014

14 FDA publishes guidance on ANDA submissions Full Text BioPharm International, July 18, 2014    Free full text

15 Efficacy and safety profile of pradaxa (dabigatran etexilate) repeatedly confirmed Full Text Boehringer Ingelheim, July 25, 2014    Free full text

16 Novartis personalized cell therapy receives FDA breakthrough therapy designation Full Text BioPharm International, July 11, 2014    Free full text

17 The bmj does make mistakes - and big ones too Full Text Applied Clinical Trials, May 21, 2014    Free full text

18 National trends in US hospital admissions for hyperglycemia and hypoglycemia among medicare beneficiaries, 1999 to 2011 JAMA Internal Medicine, July 15, 2014    Evidence Based Medicine    Clinical Article

19 Duke team brings life-saving function to ketchup packets Duke University Health & Medicine News, July 3, 2014

20 Gefitinib for oesophageal cancer progressing after chemotherapy (COG): A phase 3, multicentre, double-blind, placebo-controlled randomised trial The Lancet Oncology, June 30, 2014    Clinical Article

Indexed Journals in Pharma News: U.S.Pharmacist, FDA Drug Alerts, Pharmiwebmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register
Upcoming Clinical Trials UPCOMING Clinical Trials

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More